Alcohol’s Effects on Maternal and Fetal Blood

A New Study Shows Alcohol’s Distinct Effects on Maternal and Fetal Blood, With Clear Sex Differences

A new study provides one of the most detailed looks yet at how alcohol consumption during pregnancy disturbs biological signals in both the mother and fetus. The research, led by a French team from Université Paris Cité and other institutions, analyzed 29 proteins in blood from 21 mothers who drank alcohol during pregnancy and their newborns. They found that prenatal alcohol exposure (PAE) creates different patterns of disrupted proteins in the mother’s blood compared to the baby’s umbilical cord blood. Perhaps more strikingly, 36% of these disrupted proteins were specific to male fetuses, 48% to females, and only 16% were common to both sexes. This points to sex-specific biological responses to alcohol before birth, a finding that could change how researchers approach diagnosis and study of fetal alcohol spectrum disorders (FASDs).

Placental Biology and Brain Development

The study is grounded in the growing field of neuroplacentology. This discipline explores how the placenta, far from being just a passive filter, actively produces and releases factors that guide fetal brain development. These factors circulate in both maternal and fetal blood. When this placental communication is disturbed, it may contribute to neurodevelopmental issues. The study authors proposed that alcohol might cause such a disturbance, specifically triggering what they term an “angio-inflammatory” response—a disruption linked to both blood vessel formation (angiogenesis) and inflammation.

The Search for Biological Signals in Blood

Researchers used a preclinical database to identify candidate proteins involved in angiogenesis and inflammation. They then measured these proteins using a multiplex immunoassay, a technique that allows simultaneous measurement of multiple proteins in small blood samples. The team compared protein levels in blood from two groups: mothers with alcohol consumption during pregnancy and their newborns, and a control group of mothers with no reported alcohol use and their newborns. After identifying which proteins were dysregulated, they used bioinformatics tools (STRING and ShinyGO) to map how these proteins interact and what biological pathways they influence.

Key Findings: Separation and Specificity

The results revealed two major layers of complexity in how the body responds to prenatal alcohol exposure.

Maternal and Fetal Compartments Tell Different Stories

The profile of dysregulated proteins in the mother’s blood was distinct from the profile found in the baby’s umbilical cord blood. This means that measuring biological changes in the mother may not directly reflect what is happening to the fetus. It emphasizes the fetus as a separate patient with its own unique biological response to the prenatal environment. For both clinicians and researchers, it suggests that biomarkers for fetal alcohol exposure might need to be measured directly in fetal or neonatal blood, not just maternal blood.

Sex Differences Are Pronounced

The sex-specific findings were particularly notable. Out of all the dysregulated proteins identified:

• 48% were found only in pregnancies with female fetuses.
• 36% were found only in pregnancies with male fetuses.
• A mere 16% were shared between the sexes.

This suggests male and female fetuses mount different biological responses to alcohol exposure. These distinct “signatures” could partly explain why the presentation and severity of FASDs can vary so much between individuals and why boys and girls may have different vulnerabilities or outcomes.

Pathways Point to Vascular Stress

The bioinformatics analysis of the dysregulated proteins showed they were not random. The proteins interacted strongly with each other, connecting inflammatory and angiogenic functions. The ShinyGO analysis further indicated these proteins are involved in pathways related to “vascular shear stress.” This is a type of mechanical force exerted on blood vessel walls by blood flow. The finding implies that alcohol exposure might affect fetal development by disrupting the delicate forces and signals involved in building a healthy circulatory system, which is vital for organ and brain development.

Limitations and the Preprint Status

This study offers a compelling but preliminary view. Several important limitations must be considered.

Small Sample Size and Preprint Nature

The study involved 21 mother-newborn pairs in the PAE group. This is a relatively small number, and the findings need to be validated in larger, more diverse populations. Most critically, this research is a preprint. It has been shared publicly on the medRxiv server but has not yet undergone the formal peer-review process. In peer review, independent experts scrutinize the methodology, analysis, and conclusions. The final published version may differ, and the findings require confirmation by other research teams.

Measurement and Causation Questions

The study measured alcohol consumption through maternal self-report, which can be subject to under-reporting due to social stigma. The exact timing, amount, and pattern of drinking were not detailed. Furthermore, while the study shows associations between alcohol consumption and dysregulated proteins, it cannot definitively prove that alcohol directly caused these specific changes or that these changes directly cause later neurodevelopmental problems. They are strong biological clues, not established causal pathways.

What This Means for Parents and Practitioners

Despite its preliminary status, this study has clear implications for how we understand alcohol use in pregnancy.

Reinforcing the “Why” Behind Abstinence

The research adds a new layer of biological evidence to explain why there is no known safe amount of alcohol during pregnancy. It shows that alcohol exposure triggers measurable biological disruption in both mother and fetus, affecting systems critical for healthy development. For expectant parents, this reinforces the recommendation of complete abstinence as the safest choice.

A Step Toward Better Diagnosis

FASDs are often under-diagnosed or misdiagnosed. A major reason is the lack of a reliable biological test. This study moves the field forward by identifying specific candidate proteins in neonatal blood that correlate with alcohol exposure. If validated, these could one day contribute to an objective biomarker panel to aid early diagnosis. Early diagnosis is essential for connecting children with supportive interventions and therapies sooner.

The Importance of Sex in Prenatal Research

The stark sex differences serve as a critical reminder that male and female fetuses may experience prenatal exposures differently. Future research on prenatal risks, and potentially clinical guidance, must account for fetal sex. It also suggests that a one-size-fits-all approach to understanding or diagnosing conditions like FASD may be insufficient.

Key Takeaways

• Prenatal alcohol exposure creates distinct biological signatures in the mother’s blood and the baby’s blood. This means the fetal response is separate and must be studied directly.
• Male and female fetuses show very different biological responses to alcohol. 84% of the dysregulated proteins in this study were specific to one sex.
• The affected proteins are involved in inflammation, blood vessel formation, and vascular stress pathways. This suggests alcohol may harm development by disrupting these systems.
• The study is a preprint with a small sample size. The findings are promising but require peer review and replication in larger groups.
• It supports the rationale for alcohol abstinence in pregnancy by detailing the tangible biological disturbances that can occur.
• The research points toward potential future biomarkers for FASD. This could eventually help in creating objective tests for earlier, more accurate diagnosis.

This article is for informational purposes only. Consult a qualified professional for personalised advice.

---

Source:
Alcohol consumption during pregnancy dysregulates maternofetal angiogenic and inflammatory factors with sex specificities (medRxiv preprint, 2026-07-17)